Clinical Trials Logo

Dysphagia clinical trials

View clinical trials related to Dysphagia.

Filter by:

NCT ID: NCT04542551 Completed - Dysphagia Clinical Trials

Pragmatic Approach To Esophageal Dilation

Start date: March 24, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to better understand the role of a technique called esophageal dilation in patients who complain of trouble swallowing. In patients with esophageal stricture we want to determine if the size of the esophageal dilator makes a difference in symptoms and outcomes. In patients who do not have an obvious esophageal stricture we want to determine if esophageal dilation is an effective therapy in these patients.

NCT ID: NCT04532398 Completed - Dysphagia Clinical Trials

Validation of the Gugging Swallowing Screen for the Intensive Care Unit

GUSS-ICU
Start date: August 27, 2020
Phase: N/A
Study type: Interventional

Aetiology of dysphagia after extubation is unknown and considered to be multifactorial. Use of a standardized dysphagia- screening permits an early diagnosis. This study is to evaluate a new GUSS (gugging swallowing Screen) tool with multi-consistency check for intensive care patients (GUSS-ICU) with dysphagia. The concurrent validity (in terms of sensitivity and specificity) of the GUSS-ICU is analyzed in comparison to the flexible endoscopic evaluation of swallowing (FEES).

NCT ID: NCT04509752 Completed - Covid19 Clinical Trials

Dysphagia Management During COVID-19 Pandemic

Start date: October 8, 2020
Phase:
Study type: Observational

The current study is aimed to determine the procedures applied in the dysphagia clinics during the COVID-19 pandemic period. A questionnaire consisting of 30 questions will be implemented. Each participant will be asked to answer the questions.

NCT ID: NCT04421937 Completed - Stroke Clinical Trials

The Effects of Neuromuscular Electrical Stimulation on Swallowing Functions in Stroke Patients With Dysphagia

Start date: April 15, 2020
Phase: N/A
Study type: Interventional

In our study, our aim is to evaluate the effect of neuromuscular electrical stimulation added to traditional dysphagia therapy in stroke patients with dysphagia, on functional oral intake status, dysphagia-related symptoms, quality of life, and complications related to dysphagia.

NCT ID: NCT04402307 Completed - Dysphagia Clinical Trials

Effect of Training of Patients With Dysphagia

Start date: March 25, 2019
Phase: N/A
Study type: Interventional

Effect of training of patients with dysphagia

NCT ID: NCT04369092 Completed - Multiple Sclerosis Clinical Trials

Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia

Start date: October 2, 2019
Phase: N/A
Study type: Interventional

Multiple Sclerosis is a chronic inflammatory autoimmune neurological disease characterized by the destruction of myelin in the central nervous system, grey matter and axonal loss. The prevalence of neurogenic dysphagia in this group of patients is estimated to be more than 30%. The aim of this study was investigating of Masseter, Orbicularis Oris, Sternocleidomastoid muscles' viscoelastic properties in MS patients with and without swallowing problems.

NCT ID: NCT04347395 Completed - Pneumonia Clinical Trials

Respiratory Infection in Older Patients

Start date: January 29, 2016
Phase: N/A
Study type: Interventional

This randomized controlled trial in older hospitalized patients found that a respiratory care bundle intervention did not significantly reduce the incidence of respiratory infections compared to usual care for the index admission. However, time to next admission for respiratory infection was significantly longer with the intervention compared to usual care. Aim: To evaluate whether a respiratory care bundle, compared to usual care, reduces respiratory infections during and after hospitalization. Methods: In this open-label, single-centre randomized controlled trial, we recruited patients >65 years of age and admitted <72 hours for non-respiratory conditions to a novel respiratory care bundle intervention (whole bed tilt, swallow screen, chlorhexidine mouth wash, and pneumococcal and influenza vaccinations) or usual care. Participants were followed up for 12 months. The primary endpoint was the development of respiratory infection during the index admission. The secondary endpoint was the time to next admission for respiratory infection.

NCT ID: NCT04305860 Completed - Dysphagia Clinical Trials

Acceptance of Different Thickeners in Dysphagia

Start date: February 3, 2020
Phase: N/A
Study type: Interventional

Randomized, controlled, pilot study of nutritional intervention to evaluate the acceptance to different kinds of thickeners, with and without the addition of flavoring.

NCT ID: NCT04302883 Completed - Dysphagia Clinical Trials

Transesophageal Echocardiography: Dysphagia Risk in Acute Stroke (T.E.D.R.A.S. Trial)

TEDRAS
Start date: June 12, 2013
Phase: N/A
Study type: Interventional

The prevalence of dysphagia in acute stroke patients undergoing transesophageal echocardiography (TEE) is unknown. The aim of this study was to assess for the first time whether TEE has a negative influence on swallowing in acute stroke patients.

NCT ID: NCT04182178 Completed - Dysphagia Clinical Trials

Long-term Follow-up After Surgical Treatment for GERD (Gastroesophageal Reflux Disease)

Start date: August 5, 2019
Phase:
Study type: Observational

10 years of follow-up with SF-36 global (Quality of Life issues), GSRS (Gastrointestinal Symptom Rating Scale) and two reflux specific questionnaires.